CAMBRIDGE, Mass., March 26 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that
management will present a corporate overview at the upcoming
Canaccord Adams' Hepatitis C Conference on Thursday, April 1, 2010 at 10:45 a.m. ET at The Peninsula Hotel,
New York.
The live and archived webcast of the company presentation can be
accessed under "Calendar of Events" in the Idenix Investor Center
at www.idenix.com. Please log in approximately 5-10 minutes
before the event to ensure a timely connection. The archived
replay will be available on the Idenix website for two weeks
following the conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development
of drugs for the treatment of human viral diseases. Idenix's
current focus is on the treatment of infections caused by the
hepatitis C virus. For further information about Idenix, please
refer to http://www.idenix.com.
Idenix
Pharmaceuticals Contact:
|
|
Teri Dahlman (617)
995-9905
|
|
|
SOURCE Idenix Pharmaceuticals, Inc.